An investing notebook, since 2011

Patient investing, written down.

Company analysis, valuation frameworks, momentum systems and the tools behind them, from India to the US and Australia. 333 essays across 15 years, every one free to read.

New writing, by email

Free posts arrive in your inbox. Paid subscribers read new research six months before it comes to this site.

Subscribe